RSV疫苗市场的高光仅维持了一年,有两款疫苗全球销售额现下滑

第一财经
07 Feb

经过60多年的研究,直到2023年,全球才终于迎来RSV(呼吸道合胞病毒)疫苗上市,当年有两款疫苗实现上市,分别是葛兰素史克的Arexvy以及辉瑞的Abrysvo,但这两款疫苗的高光时刻仅维持了一年。  葛兰素史克和辉瑞近期发布的2024年财报显示,这两款疫苗全球销售额均出现下滑。  具体看,2024年,葛兰素史克的RSV疫苗Arexvy全年销售额仅为5.90亿英镑(约7.56亿美元),同比减少...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10